Human FOXO3 (FOXO3A) knockout HEK-293T cell lysate
Be the first to review this product! Submit a review
|
(0 Publication)
FOXO3 KO cell lysate available now. KO validated by Western blot. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, Homozygous: 10 bp deletion in exon 1.
View Alternative Names
AF6q21, AF6q21 protein, DKFZp781A0677, FKHR2, FKHRL 1, FKHRL1P2, FOXO2, FOXO3_HUMAN, Forkhead (Drosophila) homolog (rhabdomyosarcoma) like 1, Forkhead Drosophila homolog of in rhabdomyosarcoma like 1, Forkhead box O3, Forkhead box O3A, Forkhead box protein O3, Forkhead box protein O3A, Forkhead homolog (rhabdomyosarcoma) like 1, Forkhead in rhabdomyosarcoma-like 1, MGC12739, MGC31925
- WB
Lab
Western blot - Human FOXO3 (FOXO3A) knockout HEK-293T cell lysate (AB256922)
This data was developed using the same antibody clone in a different buffer formulation (ab109629).
Lanes 1 - 4 : Merged signal (red and green). Green - ab109629 observed at 82 kDa. Red - loading control ab8245 (Mouse anti-GAPDH antibody [6C5]) observed at 37 kDa.
ab109629 was shown to react with FOXO3A in wild-type cells in Western blot with loss of signal observed in FOXO3 knockout cellS. Wild-type and FOXO3 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3 % milk in TBS-T (0.1 % Tween®) before incubation with ab109629 and ab8245 (Mouse anti-GAPDH antibody [6C5]) overnight at 4 °C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-FOXO3A antibody [EPR1950] (<a href='/en-us/products/primary-antibodies/foxo3a-antibody-epr1950-ab109629'>ab109629</a>) at 1/1000 dilution
Lane 1:
Wild-type HEK-293T cell lysate at 20 µg
Lane 2:
Western blot - Human FOXO3 (FOXO3A) knockout HEK-293T cell lysate (ab256922) at 20 µg
Lane 2:
Western blot - Human FOXO3 (FOXO3A) knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-foxo3-foxo3a-knockout-hek-293t-cell-line-ab265069'>ab265069</a>)
Lane 3:
Wild-type HEK-293 cell lysate at 20 µg
Lane 4:
Western blot - Human FOXO3 (FOXO3A) knockout HEK-293 cell lysate (<a href='/en-us/products/cell-lysates/human-foxo3-foxo3a-knockout-hek-293-cell-lysate-ab261649'>ab261649</a>) at 20 µg
Predicted band size: 71 kDa
Observed band size: 82 kDa
false
- WB
Lab
Western blot - Human FOXO3 (FOXO3A) knockout HEK-293T cell lysate (AB256922)
Lane 1 : Wild-type HEK-293T cell lysate 20 ug
Lane 2 : FOXO3 knockout HEK-293T cell lysate (ab256922) 20 ug
Lane 3 : Wild-type HEK-293 cell lysate 20 ug
Lane 4 : FOXO3 knockout HEK-293 cell lysate (ab261649) 20 ug
Lanes 1 - 4 : Merged signal (red and green). Green - ab23683 observed at 82 kDa. Red - loading control ab8245 (Mouse anti-GAPDH antibody [6C5]) observed at 37 kDa.
ab23683 was shown to react with FOXO3A in wild-type HEK-293T cells in Western blot with loss of signal observed in FOXO3 knockout cell line ab265069 (FOXO3 knockout cell lysate ab256922). Wild-type HEK-293T and FOXO3 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3 % milk in TBS-T (0.1 % Tween®) before incubation with ab23683 and ab8245 (Mouse anti-GAPDH antibody [6C5]) overnight at 4 °C at 1 μg/ml and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-FOXO3A antibody (<a href='/en-us/products/primary-antibodies/foxo3a-antibody-ab23683'>ab23683</a>) at 1 µg/mL
Lane 1:
Wild-type HEK-293T cell lysate at 20 µg
Lane 2:
Western blot - Human FOXO3 (FOXO3A) knockout HEK-293T cell lysate (ab256922) at 20 µg
Lane 2:
Western blot - Human FOXO3 (FOXO3A) knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-foxo3-foxo3a-knockout-hek-293t-cell-line-ab265069'>ab265069</a>)
Lane 3:
Wild-type HEK-293 cell lysate at 20 µg
Lane 4:
Western blot - Human FOXO3 (FOXO3A) knockout HEK-293 cell lysate (<a href='/en-us/products/cell-lysates/human-foxo3-foxo3a-knockout-hek-293-cell-lysate-ab261649'>ab261649</a>) at 20 µg
Predicted band size: 71 kDa
Observed band size: 82 kDa
false
- Sanger seq
Unknown
Sanger Sequencing - Human FOXO3 (FOXO3A) knockout HEK-293T cell lysate (AB256922)
Homozygous : 10 bp deletion in exon 1
Reactivity data
Product details
Knockout cell lysate achieved by CRISPR/Cas9.
REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.
User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.
This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.
What's included?
Properties and storage information
Gene name
Gene editing type
Gene editing method
Knockout validation
Zygosity
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
FOXO3A acts as a regulator of genes involved in cell cycle arrest apoptosis and DNA repair. It is not part of a simple protein complex but works closely with multiple factors to influence cellular homeostasis. Significantly FOXO3A controls the expression of Bcl-2 a protein important for cell survival and the protein p27 which is important for cell cycle control. FOXO3A's activity modulates cellular longevity and impacts stress responses highlighting its abundant biological functions.
Pathways
FOXO3A integrates into the PI3K/AKT and the insulin signaling pathways both essential for cellular metabolism and proliferation control. In the PI3K/AKT pathway FOXO3A functionally links with proteins such as AKT and PTEN where its activity can be inhibited by AKT-mediated phosphorylation. In doing so it supports a balance between cell survival and apoptosis allowing the cell to adjust to growth conditions and external stressors effectively.
Quality control
STR analysis
CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX
Cell culture
Biosafety level
EU: 2 US: 2
Adherent/suspension
Adherent
Gender
Female
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com